# Viatris: Dawn score and attention ranking

Viatris scores 45 out of 100 on the Dawn Index, built from 4 signals. It ranks #5 of 7 in Pharmaceuticals (S&P 500), #49 of 57 in Health Care (S&P 500), #321 of 455 in S&P 500.

## What drives the Viatris Dawn score?

| Signal | Weight | Score (0 to 100) |
| --- | --- | --- |
| Search scale | 20% | 49 |
| Search momentum | 20% | 36 |
| Site scale | 15% | 40 |
| Site momentum | 10% | 54 |

## How does Viatris compare in Pharmaceuticals (S&P 500)?

| Rank | Brand | Dawn score |
| --- | --- | --- |
| 1 | [Johnson & Johnson](https://dawntrend.com/brand/johnson-johnson) | 55 |
| 2 | [Bristol Myers Squibb](https://dawntrend.com/brand/bristol-myers-squibb) | 51 |
| 3 | [Pfizer](https://dawntrend.com/brand/pfizer) | 49 |
| 4 | [Zoetis](https://dawntrend.com/brand/zoetis) | 48 |
| 5 | [Viatris](https://dawntrend.com/brand/viatris) | 45 |
| 6 | [Merck & Co.](https://dawntrend.com/brand/merck-co) | 41 |
| 7 | [Lilly (Eli)](https://dawntrend.com/brand/lilly-eli) | 35 |

## Where do the numbers come from?

Search figures are Google search estimates for the brand and its products. Site figures are third-party traffic estimates. A Dawn score measures attention, not revenue.

See the full Dawn Index.